Mechanism of action of vinpocetine

Kiss B, Karpati E.

Richter Gedeon Vegyeszeti Gyar Rt.,
Farmakologiai Kutato Kozpont, Budapest
Acta Pharm Hung 1996 Sep;66(5):213-24

Abstract

Vinpocetine was introduced into the clinical practice some twenty years ago in Hungary for the treatment of cerebrovascular disorders and related symptoms.  Since then, its active ingredient, vinpocetine, beside its therapeutical utilization, has become a reference compound in the pharmacological research of cognitive deficits caused by hypoxia and ischaemia as well as in the cellular and biochemical investigations related to cyclic nucleotides.  In this review a survey is given on the experimental data obtained with vinpocetine and an attempt is made to outline the drug's mechanism of action. 

Early experiments with vinpocetine indicated five main pharmacological and biochemical actions: 

(1) selective enhancement of the brain circulation and oxygen utilization without significant alteration in parameters of systemic circulation, 
(2) increased tolerance of the brain toward hypoxia and ischemia, 
(3) anticonvulsant activity, 
(4) inhibitory effect on phosphodiesterase (PDE) enzyme,
(5) improvement of rheological properties of the blood and inhibition of aggregation of thrombocytes. 

Later studies in various laboratories confirmed the above effects and clearly demonstrated that vinpocetine offers significant and direct neuroprotection both under in vitro and in vivo conditions. Evidence has been obtained that neuroprotective action vinpocetine is related to the inhibition of operation of voltage dependent neuronal Na(+)-channels, indirect inhibition of some molecular cascades initiated by the rise of intracellular Ca(2+)-levels and, to a lesser extent, inhibition of adenosine reuptake.  Vinpocetine has been shown to be selective inhibitor of Ca(2+)-calmodulin dependent cGMP-PDE.  It is assumed that this inhibition enhances intracellular a GMP levels in the vascular smooth muscle leading to reduced resistance of cerebral vessels and increase of cerebral flow.  This effect might also beneficially contribute to the neuroprotective action.

Home | Order
www.AlzheimersTreatments.com

   1.   vinpocetine  treatment in acute stroke
   2.   vinpocetine  redistributes cerebral blood flow in post-stroke patients
   3.   vinpocetine  cerebral effects on stroke patients
   4.   vinpocetine  mechanism of action
   5.   vinpocetine  increases cerebral blood flow in stroke patients 
   6.   vinpocetine  in the treatment of cerebrovascular disorders
   7.   vinpocetine  as a free radical scavenger
   8.   vinpocetine  safety
   9.   vinpocetine  treatment for vascular senile cerebral dysfunction
 10.   vinpocetine  safety and efficacy
 11.   vinpocetine  improved visual acuity in 88% of subjects
 12.   vinpocetine  is indicated in ischemic disorders of cerebral circulation
 13.   vinpocetine  might increase adaptation to hypoxia
 14.   vinpocetine  use in dementia
 15.   vinpocetine  significantly reduced neuronal cell loss
 16.   vinpocetine  caused significant and quick improvement in vascular diseases
 17.   vinpocetine  increases cerebral blood flow
 18.   vinpocetine  enhances the glycolytic and oxidative glucose breakdown in CNS
 19.   vinpocetine  increases regional cerebral blood flow
 20.   vinpocetine  enhances oxygen release in vascular dementia 
 21.   vinpocetine  has a protective effect against cerebral ischemia
 22.   vinpocetine  improvemed red blood cell deformability in stroke patients
 23.   vinpocetine  study of patients with cerebrovascular disorders
 24.   vinpocetine  improved 87% of patients with central nervous system disorders
 25.   vinpocetine  significantly improved memory
 26.   vinpocetine  dose of 5mg caused increased cerebral blood flow
 27.   vinpocetine  might prove effective in augmenting cerebral blood flow
 28.   vinpocetine  was associated with improvement in short-term memory
 29.   vinpocetine  significant improvement in short-term memory test

Home | Order
 

 

 

 

 

 

 

Hit Counter